The Food and Drug Administration on Wednesday approved Rasonque, a once-daily pill developed by Revolution Medicines to block several forms of the RAS protein — the mutation that drives tumor growth in most pancreatic cancers, and in roughly a quarter of all human cancers overall. For investors like Dr. Danish Nagda, an early shareholder in
The price tag for General Motors’ electric vehicle reboot has soared to nearly $11 billion. During the automaker’s Tuesday earnings update, executives said GM recorded an electric vehicle-related charge of nearly $2.3 billion in the most recent quarter. That brings the automaker’s total related costs to $10.9 billion from the second half of 2025, as